Plasma levels of neuropeptides in Alzheimer's disease

Author： Proto Caterina   Romualdi Daniela   Cento Rosa   Spada Rosario   Di Mento Giuseppina   Ferri Raffaele   Lanzone Antonio  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.22, Iss.4, 2006-04, pp. : 213-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Plasma Levels of Antioxidants Are Not Associated with Alzheimer’s Disease or Cognitive Decline

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 2-3, 2005-02 ,pp. : 134-139

Karger

Access to resources Recommend Favorite

Decrease of TGF- 1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease

By De Servi B.   La Porta C.A.M.   Bontempelli M.   Comolli R.  

Experimental Gerontology, Vol. 37, Iss. 6, 2002-06 ,pp. : 813-821

Elsevier

Access to resources Recommend Favorite

Low Plasma ApoE Levels Are Associated with Smaller Hippocampal Size in the Alzheimer's Disease Neuroimaging Initiative Cohort

By  

Dementia and Geriatric Cognitive Disorders, Vol. 39, Iss. 3-4, 2014-12 ,pp. : 154-166

Karger

Access to resources Recommend Favorite

Cognitive Performance and Plasma Levels of Homocysteine, Vitamin B12, Folate and Lipids in Patients with Alzheimer Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 4, 2008-10 ,pp. : 384-390

Karger

Access to resources Recommend Favorite

Effects of glucocorticoids on oxidative stress-induced hippocampal cell death: implications for the pathogenesis of Alzheimer's disease - Reversal by tachykinin neuropeptides

By Behl C.  

Experimental Gerontology, Vol. 33, Iss. 7, 1998-11 ,pp. : 689-696

Elsevier

Access to resources Recommend Favorite